Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis
Study sponsor: Tvardi Therapeutics, Incorporated
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-08-14Actual
Enrollment · participants100Actual
Source updated2026-08-13Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.